Delivery Order SPE2DE24DA010-SPE2D626F95L9
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a $34,732.80 fixed-price delivery order (Contract 4570380875, GALLANT) from the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with completion targeted for January 6, 2026. The delivery order, issued without set-aside designation, will be performed in Santa Clara, California, and represents a task order execution under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $28,350 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment is scheduled for completion by January 20, 2026, and will be performed in Santa Clara, California. The delivery order carries no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F95L9Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $25,875.85 fixed-price delivery order (Contract No. 4570444146, GALLANT) by the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with performance completion targeted for January 13, 2026. The award was made without set-aside designation through full and open competition and will be performed in Santa Clara, California. This delivery order represents a discrete procurement action under Abbott's established relationship with the Defense Logistics Agency, leveraging the company's extensive portfolio of cardiovascular medical technologies and its role as a critical supplier within the federal medical supply infrastructure. Abbott Vascular Inc. has established itself as a strategic partner to federal healthcare agencies through its specialization in advanced cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, left ventricular assist devices, and transcatheter valve repair systems. The company maintains significant indefinite delivery contracts with the Defense Logistics Agency, including a major $117.1 million vehicle for comprehensive cardiovascular procedural packages that has generated numerous task orders throughout 2024 and 2025. This current delivery order reflects Abbott's consistent success in competing for federal healthcare procurement opportunities and demonstrates its operational capacity to support both discrete device deliveries and integrated procedural packages essential to military and veteran healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 1/7/26 |